Table 1.
Baseline Characteristics of the Study Population
| All Patients | Patients With Significant CAD | Patients Without Significant CAD | P Valuea | |
|---|---|---|---|---|
| n (%) | 271 | 92 (34) | 179 (66) | ··· |
| Age, y | 57.04±9.65 | 58.91±10.10 | 56.08±9.28 | 0.022 |
| Men, n (%) | 158 (58) | 70 (76) | 84 (47) | <0.001 |
| Heart rate (bpm) | 72.96±9.35 | 74.40±10.87 | 72.22±8.40 | 0.093 |
| SBP, mm Hg | 136.19±13.49 | 136.65±14.56 | 135.96±12.95 | 0.690 |
| DBP, mm Hg | 76.64±9.14 | 77.65±7.35 | 76.13±9.92 | 0.156 |
| PP, mm Hg | 59.55±15.82 | 59.01±15.72 | 59.83±15.91 | 0.684 |
| Hypertension, n (%) | 125 (46) | 43 (47) | 82 (46) | 0.884 |
| ACEI or ARB, n (%) | 48 (18) | 18 (20) | 30 (17) | 0.567 |
| CCB, n (%) | 91 (34) | 36 (39) | 55 (31) | 0.165 |
| β‐blocker, n (%) | 34 (13) | 12 (13) | 22 (12) | 0.859 |
| BMI (kg/m2) | 24.69±2.43 | 25.13±2.26 | 24.46±2.49 | 0.032 |
| Diabetes mellitus, n (%) | 33 (12) | 15 (16) | 18 (10) | 0.136 |
| Hypercholesterolemia, n (%) | 44 (16) | 16 (17) | 28 (16) | 0.712 |
| LDL‐C (mmol/L) | 2.85±0.83 | 2.83±1.13 | 2.85±0.68 | 0.910 |
| HDL‐C (mmol/L) | 1.32±0.41 | 1.26±0.29 | 1.34±0.44 | 0.198 |
| Smoker, n (%) | 82 (30) | 42 (46) | 40 (22) | <0.001 |
Continuous data are presented as mean±SD and categorical data as number (percentage). ACEI indicates angiotensin‐converting enzyme inhibitor; ARB, angiotensin receptor inhibitor; BMI, body mass index; CAD, coronary artery disease; CCB, calcium‐channel blocker; DBP, diastolic blood pressure; HDL‐C, high‐density lipoprotein cholesterol; LDL‐C, low‐density lipoprotein cholesterol; PP, pulse pressure; SBP, systolic blood pressure.
a
Comparison between patients with and without significant CAD.